FREE CASE EVALUATION: CALL 1-800-632-1404
A recent research report published in the Pharmacotherapy journal has suggested “statistically significant association between first-time testosterone use and heart attack risk.” The findings are significant for a testosterone attorney evaluating adverse events and wrongful death claims. Some reports blame supplement makers for hiding side effect information for profits, and there has been a surge in testosterone therapy lawsuits against makers of Anrogel, Testim, and similar low-t drugs.
According to the latest findings, men using testosterone replacement therapy for the first time are more likely to suffer from heart problems than those not using it. Made public on January 13, 2015, the report prepared by scholars from the British Columbia University pegs the risk as 40 percent higher. The study involved examination of medical records of about “1 million men from ages 45-80.”
Reports Blame Drug Makers for “Hiding” Testosterone Heart Attack Risk
A number of testosterone therapy heart attack lawsuits seek compensation claiming that they have been defrauded by drug manufacturers.
An August 2013 report in the Journal of the American Medical Association entitled Low “T”: How to Sell Disease, documented extensively efforts by testosterone supplement producers to manipulate consumers through influenced doctors, sales representatives, marketing promotions, unproven claims, and funded studies into using their Low-T products even if there is no need of it. It called for greater vigilance and research before using the therapy. It expressed alarm at the growing use of testosterone replacement therapy for lifestyle reasons, sex drive, and strength gain and a failure of the pharmaceutical industry to warn about its side effects.
The New York Times reported on February 3, 2014, that supplement manufacturers were aware of serious testosterone heart attack risk nearly a decade earlier than users and the medical professionals highlighted it. It hinted at results of a clinical trial conducted by Boston-based researchers in the early 2000’s that discovered a five-fold rise in testosterone heart attack risk.
Researchers administered Low-T medications to hundreds of men and found considerable enhancements in their energy and strength levels. However, most of them were diagnosed with testosterone-linked cardiovascular complications, such as enhanced risk of stroke and heart attack. It was discovered that those taking testosterone therapy were five-time more susceptible to heart attack than those treated with placebo. The study continued until 2010 without any public disclosure of findings and manufacturers have been aggressively marketing sell Low-T supplements without cardiovascular disorder information.
The Endocrine Society, a body of endocrinology experts in the United States, has called for safety assessment studies on the heart attack risk posed by testosterone therapy. Many consumer groups and experts are critical of aggressive marketing Low-T supplements despite complaints of serious cardiovascular risks in users.
All these findings have reinforced the contention of a testosterone attorney and plaintiffs filing lawsuits that the manufacturer suppressed risk data for commercial gains.
Testosterone Therapy Heart Attack
Testosterone therapy causes a significant increase in risk of heart attack and consequent death risk when administered to seniors or younger men with potential cardiovascular problems. The major cardiovascular complications associated with testosterone therapy are:
- Heart attack
- Stroke
- Blood clots leading to arterial disruptions or Pulmonary Embolism
The Journal of the American Medical Association reported a potential link between testosterone therapy and heart attack risk in November 2013 that resulted in many users seeking to file product liability lawsuits. On January 31, 2014, the FDA announced an investigation into the risk of heart attack, stroke, and other cardiovascular disorders associated with testosterone therapy.
A recent study reported in the PLOS ONE medical journal warns of a close association between heart attack and use of testosterone gel, patch, and other supplements. Published on January 29, 2014, the report highlights that seniors without history of cardiovascular disorder and young men with previous cardiac complications face 36 percent more risk of heart attacks when using the testosterone therapy.
If you are victim of similar injures or suffered adverse events linked to Low- T drugs, contact us or call on 1-800-632-1404 for evaluation of your potential low-t drug injury claim by our experienced testosterone attorney.
To Contact a Testosterone Lawyer:
If you or a loved one have experienced a testosterone replacement therapy injury after undergoing low testosterone therapy, please contact our team of lawyers today for a free case evaluation at:
CALL: 1-800-632-1404
FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:
NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.
One Reply to “Testosterone Attorney Says New Study Supports Testosterone Therapy Heart Attack Risk”